Strategic portfolio planning is crucial for developing long-term company strategy.

The goal is to meet strategic objectives selecting the "best" portfolio of internal and external drug development programs for funding and balance company resources including money, manpower and manufacturing capacity. Projects could be interdependent, have multiple development scenarios, and are subject to multiple business rules specific for the company environment. Value of each project depends on multiple factors, and could be quantitative or qualitative.

Strategic portfolio planning should be based on robust data collection processes. During the webinar we will discuss what data we need, and how to derive them.

Without specific tools, portfolio planning process could be extremely slow and cumbersome process. However, many of tools have limited capabilities. We believe that most comprehensive solution could be based on optimization modeling providing flexible and powerful portfolio analysis. During the webinar we will discuss intuitive examples and case studies, illustrating benefits of optimization approach for portfolio planning.

Why you should attend: Neglecting optimization in portfolio planning could lead to ineffective planning solutions and missing opportunities. Without proper tools any feasible portfolio planning solution looks good; However, it might be far from optimal by up to 50%. Suboptimal resource allocation as a part of portfolio planning solution, and misalignment between strategy and available resources may cause uncertainty in decision making process. Some companies use "simple" portfolio planning tools based on ranking projects. Those tools may generate ineffective solutions doubting executive management.

Areas Covered in the Session:
Overview of strategic portfolio planning for biopharmaceutical companies
Introduction to portfolio optimization
Overview of portfolio optimization model
Data collection and analysis
Case studies illustrating effectiveness of proposed approach
Optimal portfolio selection
Forced projects prioritization
Contingency planning due to a clinical trial failure
Resource bottleneck analysis
Portfolio planning with multiple goals
Who Will Benefit:
Portfolio planning, VP, Director, manager
Financial analysts, Directors, VPs, managers
Clinical Operations, VP, Director, planner, manager
Business Development, VP, Director, analyst, manager
Discovery portfolio, VP, Director, manager
Manufacturing, VP, Director, manager
Marketing, VP, Director Manager

Price List:
Live : $245.00
Corporate live : $995.00
Recorded : $295.00

webinars@globalcompliancepanel.com
http://www.globalcompliancepanel.com

Phone: 800-447-9407
Fax: 302-288-6884